Davis Select International ETF (DINT)
- Previous Close
19.87 - Open
19.93 - Bid 20.00 x 800
- Ask 20.06 x 800
- Day's Range
19.97 - 20.04 - 52 Week Range
16.75 - 20.30 - Volume
6,142 - Avg. Volume
15,034 - Net Assets 167.75M
- NAV 20.00
- PE Ratio (TTM) 11.97
- Yield 1.68%
- YTD Daily Total Return 8.15%
- Beta (5Y Monthly) 1.11
- Expense Ratio (net) 0.66%
The fund's investment adviser uses the Davis Investment Discipline to invest the fund's portfolio principally in common stocks (including indirect holdings of common stock through depositary receipts) issued by foreign companies, including countries with developed or emerging markets. The fund may invest in large, medium or small companies without regard to market capitalization.
Davis ETFs
Fund Family
Foreign Large Blend
Fund Category
167.75M
Net Assets
2018-03-01
Inception Date
Performance Overview: DINT
Trailing returns as of 4/26/2024. Category is Foreign Large Blend.
People Also Watch
Holdings: DINT
Top 10 Holdings (57.32% of Total Assets)
Sector Weightings
Related ETF News
Research Reports: DINT
ANIK: Lowering target price to $21.00
ANIKA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $21.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetANIK: Lowering target price to $22.00
ANIKA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $22.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetANIK: Lowering target price to $25.00
ANIKA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $25.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetANIK: Rating decreased to a SELL
ANIKA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $28.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice Target